MicroPort<sup>®</sup> Attends SCC 2017

Guangzhou, China – From April 6 to April 9, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") attended the 19th South China International Congress of Cardiology ("SCC 2017") held in Guangzhou, and hosted a satellite meeting and a case competition. As a premier academic exchange meeting in the cardiovascular industry, the SCC 2017 focused on academic research, application and cooperation, and attracted over 8,000 cardiologists and clinicians in attendance.
 
Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") hosted a satellite meeting "Columbus™: Navigation for the Heart." The meeting was co-chaired by Professor Yansheng Ding of Peking University First Hospital, Professor Jiangui He of the First Affiliated Hospital of Sun Yat-sen University, Professor Pingzhen Yang from Zhujiang Hospital of Southern Medical University, and Professor Yuehui Yin of the Second Affiliated Hospital of Chongqing Medical University. During the satellite meeting, Professor Wei Wei of Guangdong General Hospital shared her experience in using the Columbus™ 3D EP Navigation System ("Columbus™") and the matching catheters to treat complex arrhythmia. Professor Wei discussed with Professor Yansheng Ding about the procedure experience in Columbus™ and they both agreed that the domestically made 3D navigation system is good enough to meet the clinical needs. Professor Yingkai Cui of the 252th Hospital of PLA also echoed their opinion, saying the safety and efficacy of the radiofrequency ablation guided by 3D navigation was as good as or even superior to traditional method. Professor Cui noted that the launch of domestically made 3D navigation system Columbus™ can effectively lower the medical cost for patient. Professor Xudong Song of Zhujiang Hospital of Southern Medical University said in his speech that though the use of 3D navigation system would to some extent increase the operative cost, it largely reduces the fluoroscopy time and offers a more precise guidance for catheter ablation. The satellite meeting was finished with 3D arrhythmia case sharing by Professor Hengli Lai of Jiangxi Provincial People's Hospital. She said: "As an edge tool in the EP radiofrequency ablation, the 3D navigation system has been recognized by an increasingly more physicians and has brought benefit to a lot of arrhythmia patients." As the only domestic 3D navigation system with magnetic location and full curve display catheter, MicroPort® EP's Columbus™ and its matching catheter FireMagic™ 3D Irrigated Ablation Catheter obtained the approval from China Food and Drug Administration in 2016 and have been used in several hospitals in China with high market recognition.
 
In the thesis exchange section, Professor Ming Liang of the General Hospital of Shenyang Military delivered a speech about the prospective, multicenter, controlled clinical trial of evaluating the efficacy and safety of PathBuilder™ trans-septal system in the treatment of atrial fibrillation. It was the first time that the research result of the trans-septal system in-house developed by MicroPort® EP was released in a national level academic meeting. The section was chaired by Professor Xianhong Fang of Guangdong General Hospital and Professor Lilei Yu of Renmin Hospital of Wuhan University. Professor Liang spoke highly of the domestically made trans-septal system as it is easy to handle and shows excellent performance. After the section, Professor Yili Liu of Nanfang Hospital of Southern Medical University said she looked forward to the emergence of more outstanding domestically developed medical device like MicroPort® EP's trans-septal system.
 
During the SCC 2017, MicroPort® also hosted a seminar in the form of case contest, and a total of 14 cases signed up for the competition. The first-half of the contest was co-chaired by Professor Qiangsun Zheng of the Second Affiliated Hospital of Xi'an Jiaotong University, Professor Lixia Yang of Chengdu Military Kunming General Hospital, Professor Ruqiong Nie of Sun Yat-Sen Memorial Hospital, Professor Xie Qiang of the First Affiliated Hospital of Xiamen University, Professor Shaofen Zheng of Hunan Provincial People's Hospital. In this part to select the most challenging case, the case of "a complex CTO" by Bili Zhang of Changhai Hospital of the Second Military Medical University stood out from the competition. In the second half of the most educational case, co-chaired by Professor Dingcheng Xiang of General Hospital of Guangzhou Military Command of PLA, Professor Yan Li of Xijing Hospital of the Fourth Military Medical University, Professor Wenhua Lin of Teda International Cardiovascular Hospital, Professor Zhujun Chen of Guangdong General Hospital, and Professor Feng Yang of Kunming First People's Hospital, the case analysis of "the treatment strategy of segment elevation in lead AVR of myocardial infarction" by Zongzhuang Li of Guizhou Provincial People's Hospital took the crown. The seminar was very successful and the attendees had active interaction with the competitors. It was the sixth time for MicroPort® to host such seminar in the SCC, to help promote its stent products in the treatment of complex lesions.